Stocks
Novo Nordisk blows its lead
The pharma giant just slashed its full year guidance.
Follow corporate market share dynamics—competitive gains and losses—and the strategic shifts reshaping competitive positions across industries.
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.